FDA Warns CustomRX Facility for Cleanroom, Potency Testing

The FDA issued a warning to CustomRX of Wichita, Kansas, for serious deficiencies identified during an inspection of its compounding facility, including inadequate cleanroom conditions and product testing.
Source: Drug Industry Daily